(Q51101735)

29 March 2018

title

A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment. (English)

1 reference

29 March 2018

main subject

premenstrual syndrome

1 reference

Sundblad C

1

1 reference

29 March 2018

Wikander I

series ordinal

2

1 reference

29 March 2018

Andersch B

series ordinal

3

1 reference

29 March 2018

Eriksson E

series ordinal

4

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

29 March 2018

European Neuropsychopharmacology

published in

1 reference

29 March 2018

volume

7

1 reference

29 March 2018

issue

3

1 reference

29 March 2018

page(s)

201-206

1 reference

29 March 2018

Paroxetine: a selective serotonin reuptake inhibiting antidepressant

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

The relationship between the menstrual cycle and female sexual interest in women with PMS complaints and volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Effect of clomipramine on premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Fluoxetine treatment of severe premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Buspirone in treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2897%2900404-5

7 January 2021

10.1016/S0924-977X(97)00404-5

Identifiers

DOI

1 reference

29 March 2018

release_j2s6daw2fbdpbmuibps44s6mmi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j2s6daw2fbdpbmuibps44s6mmi

24 November 2022

mapped directly with Wikidata item

1 reference

29 March 2018